ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,550Medicare Part D Prescriptions Filled, Including Refills

Rank: 19 out of 939

$1.07M Total Retail Price of All Prescriptions

Rank: 36 out of 939

819 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
64% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 819 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

13% of this provider’s 819 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

3% of this provider’s 21,375 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
SIMVASTATIN 979 855 1 2
FUROSEMIDE 904 754 2 7
OMEPRAZOLE 895 758 3 5
METFORMIN HCL 767 617 4 8
POTASSIUM CHLORIDE 722 622 5 9
AMLODIPINE BESYLATE 611 563 6 6
WARFARIN SODIUM 573 527 7 17
LEVOTHYROXINE SODIUM 550 524 8 4
SERTRALINE HCL 546 438 9 24
GLIMEPIRIDE 483 422 10 37
LISINOPRIL 475 396 11 3
TRAMADOL HCL 428 349 12 16
CHLORTHALIDONE 421 375 13 165
METOPROLOL TARTRATE 412 377 14 10
CEPHALEXIN 350 285 15 77
ALLOPURINOL 336 306 16 31
HYDROCODONE-ACETAMINOPHEN 334 252 S3 17 1
ATENOLOL 323 253 18 19
DONEPEZIL HCL 310 295 19 30
GABAPENTIN 307 234 20 11
CLONIDINE HCL 303 213 21 39
ATORVASTATIN CALCIUM 292 270 22 22
MELOXICAM 292 225 22 14
TRIAMTERENE-HCTZ 288 237 24 33
TAMSULOSIN HCL 249 241 25 27
CLOPIDOGREL 228 194 26 28
NEXIUM 225 180 27 18
LOVASTATIN 221 168 28 46
CARVEDILOL 217 170 29 25
PRAVASTATIN SODIUM 215 188 30 13
ZOLPIDEM TARTRATE 208 164 31 20
ISOSORBIDE MONONITRATE ER 191 177 32 53
MECLIZINE HCL 191 175 32 134
LISINOPRIL-HYDROCHLOROTHIAZIDE 190 121 34 23
DIGOXIN 190 164 34 45
CRESTOR 176 163 36 34
METOPROLOL SUCCINATE 175 139 37 21
NAPROXEN 165 133 38 72
EVISTA 161 151 39 122
INSULIN SYRINGE 154 106 40 97
PLAVIX 145 129 41 48
CARBIDOPA-LEVODOPA 145 145 41 102
NAMENDA 139 139 43 49
AMITRIPTYLINE HCL 136 89 R 44 38
RANITIDINE HCL 135 82 45 35
DIOVAN 133 130 46 50
KLOR-CON 10 131 122 47 158
LIPITOR 129 120 48 127
ATENOLOL-CHLORTHALIDONE 123 107 49 164
CYCLOBENZAPRINE HCL 121 47 R 50 36
PREDNISONE 118 111 51 42
NOVOLIN 70-30 116 92 52 211
GLIPIZIDE 116 85 52 52
CIPROFLOXACIN HCL 115 104 54 54
BENAZEPRIL HCL 115 103 54 87
SULFAMETHOXAZOLE-TRIMETHOPRIM 114 89 56 64
QUETIAPINE FUMARATE 105 98 57 69
ROPINIROLE HCL 105 94 57 78
ENALAPRIL MALEATE 105 100 57 65
CELEBREX 104 103 60 106
DIOVAN HCT 94 94 61 74
AVODART 94 69 61 205
HYDROCHLOROTHIAZIDE 93 88 63 12
JANUVIA 93 77 63 110
LOSARTAN-HYDROCHLOROTHIAZIDE 92 79 65 55
CYMBALTA 92 61 65 44
NITROFURANTOIN MONO-MACRO 88 79 67 180
METOLAZONE 88 60 67 181
RAMIPRIL 86 70 69 91
GLYBURIDE 86 86 R 69 89
MIRTAZAPINE 84 84 71 56
DILTIAZEM 24HR ER 84 84 71 253
CITALOPRAM HBR 84 64 71 15
TRIAMTERENE-HYDROCHLOROTHIAZID 83 46 74 115
ADVAIR DISKUS 82 70 75 60
PROAIR HFA 80 44 76 41
AZITHROMYCIN 79 69 77 32
METHOCARBAMOL 79 57 R 77 149
FAMOTIDINE 78 69 79 62
LANTUS 77 52 80 59
SPIRONOLACTONE 75 63 81 71
GEMFIBROZIL 73 67 82 100
ZETIA 72 57 83 103
ALENDRONATE SODIUM 70 70 84 40
AMLODIPINE BESYLATE-BENAZEPRIL 69 57 85 58
VERAPAMIL ER 69 47 85 85
TRAZODONE HCL 69 37 85 26
PHENYTOIN SODIUM EXTENDED 67 42 88 99
DICYCLOMINE HCL 65 57 89 194
SOTALOL 65 64 89 252
VENTOLIN HFA 63 35 91 80
PAROXETINE HCL 59 47 92 70
NITROGLYCERIN PATCH 58 58 93 279
CARBAMAZEPINE 58 42 93 189
ESCITALOPRAM OXALATE 57 51 95 61
POLYETHYLENE GLYCOL 3350 56 45 96 57
PANTOPRAZOLE SODIUM 56 55 96 66
SUCRALFATE 56 35 96 96
SPIRIVA 55 25 99 73
QUINAPRIL HCL 55 43 99 133
RISPERIDONE 55 31 99 82
DIVALPROEX SODIUM 53 53 102 95
PROPRANOLOL HCL 53 45 102 117
GLIPIZIDE ER 52 49 104 88
METRONIDAZOLE 52 45 104 238
METHOTREXATE 51 44 106 240
FOSINOPRIL SODIUM 51 41 106 199
SEROQUEL 51 44 106 139
CLINDAMYCIN HCL 50 42 109 283
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 29, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.